Transcranial Magnetic Stimulation (TMS) for Treatment of Auditory Hallucinations
NCT ID: NCT00763841
Last Updated: 2010-01-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
18 participants
INTERVENTIONAL
1999-09-30
2008-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transcranial Magnetic Stimulation (TMS) Treatment for Patients With Persistent Auditory Hallucinations
NCT00042159
rTMS for Auditory Hallucinations Guided by Magnetoencephalography
NCT05598450
High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in Schizophrenia : a Randomized Controlled Study
NCT01022489
Targeting Auditory Hallucinations With Alternating Current Stimulation
NCT03221270
Transcranial Magnetic Stimulation (TMS) for Patients With Treatment Resistant Auditory Verbal Hallucination
NCT03762746
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Stimulation will be given daily at a particular site for three days a week
Transcranial magnetic stimulation
Stimulation will be given daily at a particular site for three days a week
2
Sham
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcranial magnetic stimulation
Stimulation will be given daily at a particular site for three days a week
Sham
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NSW Schizophrenia Fellowship
UNKNOWN
Rebecca Cooper Medical Research Foundation
UNKNOWN
The University of New South Wales
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of NSW
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Colleen Loo, MBBS, FRANZCP. MD
Role: PRINCIPAL_INVESTIGATOR
University of NSW
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Psychiatry
Sydney, New South Wales, Australia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.